Briefing
Whole genome sequencing-powered ctDNA sequencing for breast cancer detection.
Plasma from 78 people with early breast cancer was tested with the NeXT Personal MRD platform, a tumor-informed whole-genome assay, across 617 samples.
- Design: Evidence level 3
- Assay: NeXT Personal
Annals of OncologyPubMed 39914664DOI 10.1016/j.annonc.2025.01.021